Skip to main content
Medicamen Biotech Ltd. logo

Medicamen Biotech Ltd. — Investor Relations & Filings

Ticker · MEDICAMEQ ISIN · INE646B01010 LEI · 894500T0ULD27B7W4Y03 BSE.NS Manufacturing
Open in API
Filings indexed 270 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country IN India
Listing BSE.NS MEDICAMEQ

About Medicamen Biotech Ltd.

https://www.medicamen.com/

Medicamen Biotech Ltd. specializes in the research, development, and manufacturing of a diverse range of pharmaceutical formulations. The company operates manufacturing facilities compliant with international quality standards, including WHO-GMP. Its product portfolio encompasses various therapeutic segments such as oncology, cardiology, central nervous system, and anti-infectives, delivered through dosage forms like tablets, capsules, and liquid orals. A significant strategic focus is placed on its specialized oncology division, which develops complex generic formulations. The company serves global markets, leveraging its research and development capabilities to provide high-quality healthcare solutions. Its operations are supported by dedicated R&D centers focused on formulation development and process chemistry.

Recent filings

Filing Released Lang Actions
Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve the audited financial results ....
Regulatory Filings Classification · 87% confidence The document is an official notice sent to stock exchanges under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing of a forthcoming Board Meeting to consider audited financial results, dividend recommendation, and auditor appointments. It does not contain actual financial statements or the results themselves, nor is it a management change announcement. It is a routine regulatory/intimation filing under listing rules. Therefore, it falls under General Regulatory Filings (RNS).
2026-05-20 English
Disclosure of material issue
Regulatory Filings Classification · 100% confidence The document is a short disclosure letter addressed to stock exchanges regarding an incorrect event display on the NSDL portal. It clarifies that no material event has been initiated or authorized by the company and that the matter is being rectified. The document is brief (1504 characters) and serves as an informational notice rather than a financial report or detailed filing. It does not contain financial data, management discussion, voting results, or any other substantive report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-04-06 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice titled 'Intimation of Closure of Trading Window' dated March 30, 2026, addressed to stock exchanges. It informs about the closure of the trading window for directors and designated persons from April 1, 2026, until 48 hours after the declaration of audited financial results for the quarter and year ended March 31, 2026. The document does not contain any financial data or results itself, nor does it include detailed financial statements or analysis. It is a regulatory announcement related to insider trading compliance ahead of financial results disclosure. The document length is short (1680 characters), and it serves as an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and procedural notices.
2026-03-30 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It reports receipt of a cautionary letter from the National Stock Exchange of India regarding observations made by the Secretarial Auditor in the Secretarial Compliance Report for the financial year ended March 31, 2025. The document does not contain financial statements or detailed financial data but is an announcement of regulatory communication and compliance observations. It is short (3122 characters) and serves as a regulatory announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-21 English
Corrigendum
Board/Management Information Classification · 100% confidence The document is a formal announcement correcting the retirement date of two Independent Directors of the company. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about changes in the board or management. The content focuses on the cessation of directorship and correction of previously communicated information. There is no financial data, no report attached or referenced as being published, and no mention of other types of filings such as annual reports or earnings releases. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2026-02-18 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a short communication (1355 characters) addressed to stock exchanges, referencing the publication of unaudited financial results for the quarter and nine months ended December 31, 2025. It mentions that the results were approved by the Board and published in newspapers. The document itself does not contain the financial statements or detailed analysis but rather serves as a notification of the publication of these results. According to the 'Menu vs Meal' rule, such a brief announcement that a report has been published or attached should be classified as a Report Publication Announcement (RPA), not as the actual Interim/Quarterly Report (IR).
2026-02-16 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.